The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 19, 2017
Filed:
Sep. 15, 2014
Applicant:
Max-planck-gesellschaft Zur Förderung Der Wissenschaften E.v., Munich, DE;
Inventors:
Steffen Gaali, Munich, DE;
Felix Hausch, Munich, DE;
Alexander Kirschner, Munich, DE;
Xixi Feng, Munich, DE;
Andreas Bracher, Munich, DE;
Gerd Ruehter, Hamburg, DE;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 211/06 (2006.01); C07D 295/00 (2006.01); C07D 207/16 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 279/12 (2006.01); C07D 211/60 (2006.01); C07D 211/78 (2006.01); C12N 9/90 (2006.01); G06F 19/16 (2011.01);
U.S. Cl.
CPC ...
C07D 207/16 (2013.01); C07D 211/60 (2013.01); C07D 211/78 (2013.01); C07D 279/12 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C12N 9/90 (2013.01); C12Y 502/01008 (2013.01); G06F 19/16 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to compounds of the general formula (I) having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said selective FKBP51 ligand compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.